NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...

In a world first, Lipsman and his team in Sunnybrook’s Hurvitz Brain Sciences Program non-invasively breached the blood-brain barrier using a focused ultrasound procedure guided by MRI. It allowed ...